Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.920
-0.010 (-0.25%)
At close: May 29, 2026, 4:00 PM EDT
3.800
-0.120 (-3.06%)
After-hours: May 29, 2026, 5:26 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $394.27 million as of May 29, 2026. Its market cap has increased by 418.82% in one year.
Market Cap
394.27M
Enterprise Value
330.43M
1-Year Change
418.82%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $394.27M, a decrease of -51.12%. That is a compound annual growth rate of -11.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 395.27M | 65.42% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 444.53M |
| Ovid Therapeutics | 442.11M |
| Monopar Therapeutics | 437.43M |
| Century Therapeutics | 433.75M |
| Neurogene | 424.28M |
| vTv Therapeutics | 412.18M |
| Compass Therapeutics | 410.60M |
| C4 Therapeutics | 408.77M |